Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļNOTV
āļāļ·āđāļāļāļĢāļīāļĐāļąāļInotiv Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 25, 1997
āļāļĩāļāļĩāđāļMr. Robert W. Leasure, Jr.
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ1977
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļNov 25
āļāļĩāđāļāļĒāļđāđ2701 Kent Ave
āđāļĄāļ·āļāļWEST LAFAYETTE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ Capital Market Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ47906-1382
āđāļāļĢāļĻāļąāļāļāđ13174634527
āđāļ§āđāļāđāļāļāđhttps://www.inotiv.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļNOTV
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 25, 1997
āļāļĩāļāļĩāđāļMr. Robert W. Leasure, Jr.
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Dr. Nigel Brown, Ph.D.
Independent Director
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Mr. Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Ms. Terry Coelho
Independent Director
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Dr. Nigel Brown, Ph.D.
Independent Director
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ